Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dose‐specific clinical outcomes in patients with opioid use disorder treated with 24–32 mg/day of buprenorphine

Addiction(2024)10.1111/add.16600Source: DataRank Database

Dose‐specific clinical outcomes in patients with opioid use disorder treated with 24–32 mg/day of buprenorphine is a research paper published in Addiction (2024). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

12 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 5.00)OA: closedTopics (52)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Junfeng Sun ORCID,Ashley Davis,Amelia Cover,Lily Sun,Catherine Gannon

Live enrichment

PubMed:38978176 OpenAlex:https://openalex.org/W4400475053

Office of AIDS Research

Grant: HHSN269201400012C

Gilead Sciences

Merck

Gilead Sciences

Merck

FWCI

5.00

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

closedLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/add.16600

journalhttps://doi.org/10.1111/add.16600

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38978176

Fields of Study

Opioid Use Disorder TreatmentHIV, Drug Use, Sexual RiskSuicide and Self-Harm StudiesHumansBuprenorphineOpioid-Related DisordersMaleFemaleAdultOpiate Substitution TreatmentProspective StudiesMiddle AgedDose-Response Relationship, DrugTreatment OutcomeNarcotic AntagonistsHepatitis CAnalgesics, OpioidDistrict of ColumbiaCohort Studies

MeSH Terms

AdultAnalgesics, OpioidBuprenorphineDistrict of ColumbiaDose-Response Relationship, DrugFemaleHepatitis CHumansMaleMiddle AgedNarcotic AntagonistsOpioid-Related DisordersProspective StudiesCohort StudiesTreatment OutcomeOpiate Substitution Treatment

Keywords

BuprenorphineDosingMedicineOpioid use disorderCohortHeroinOpioidCohort studyProspective cohort studyInternal medicineAnesthesiaPharmacologyDrugHarm ReductionHigh‐dose BuprenorphineOpioid Epidemic Substance Use

Sustainable Development Goals

SDG 0: Good health and well-being